Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →15
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,739
Total Claims
$626K
Drug Cost
430
Beneficiaries
$1,456
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
+3%
Cost per patient vs peers
$1,456 vs $1,411 avg
+13%
Brand preference vs peers
12.0% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
26
Opioid Claims
$256
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,521 claims · $491K
Generic: 11,130 claims · $127K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 390 | $86K |
| Dulaglutide | 65 | $45K |
| Dextromethorphan Hbr/Quinidine | 77 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 117 | $24K |
| Semaglutide | 17 | $16K |
| Brexpiprazole | 11 | $16K |
| Sacubitril/Valsartan | 29 | $16K |
| Linagliptin | 81 | $16K |
| Mirabegron | 30 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $13K |
| Umeclidinium Brm/Vilanterol Tr | 28 | $12K |
| Vibegron | 63 | $12K |
| Dapagliflozin Propanediol | 20 | $12K |
| Fluticasone/Umeclidin/Vilanter | 17 | $11K |
| Empagliflozin | 14 | $10K |
Prescribing Profile
Patient Profile
72
Avg Age
60%
Female
2.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data